Sector News

Google launches virtual medical research app, starting with studies in the flu and COVID-19

December 13, 2020
Life sciences

Google has launched its own virtual clinical research app for Android phones—and it’s starting with studies into respiratory diseases such as COVID-19.

According to the tech giant, the app allows any user to sign up and volunteer to participate in medical research, after submitting data about themselves and answering a questionnaire.

The goal is to furnish a platform for scientists, who can poll the system to find the people they need to help answer their research questions. And by lowering barriers to entry, Google ultimately hopes to provide a large and diverse population of potential study participants.

In this manner, the app is similar in structure to one launched by Apple for its iPhones, iPads and smartwatches last year, which has included studies in cardiovascular health, hearing and women’s health and fertility—with one heart-focused study canvassing more than 400,000 people in less than nine months.

Google’s first project will be launched in partnership with Harvard Medical School and Boston Children’s Hospital focused on respiratory infections like influenza and the novel coronavirus.

By tracking adults across the U.S., the researchers hope to see how these diseases evolve and spread through communities, while gauging how age and different activities—such as how many daily trips a person takes outside the home—contribute to potential risk factors.

“With COVID-19 emerging alongside seasonal respiratory pathogens, research is now needed more than ever to develop more effective treatments and mitigation strategies,” said John Brownstein, Ph.D., a professor at Harvard Medical School and chief innovation officer at Boston Children’s.

Volunteers will use Google’s app to report symptoms, any preventive measures they’ve taken and medical information such as test results. Participants’ data will be encrypted, and they will have control over what is contributed and shared; no data will be sold or shared with advertisers, Google said. In addition, the app will help users access any research findings once they are published.

by Conor Hale

Source: fiercebiotech.com

comments closed

Related News

January 29, 2023

Colorcon, Inc. signs Put agreement with intent to acquire controlled atmosphere packaging specialist Airnov Healthcare Packaging

Life sciences

Airnov provides critical healthcare industries with high-quality, controlled atmosphere packaging, to protect their products from moisture and oxygen. The business has manufacturing facilities in the USA, France, China and India and employs around 700 people.

January 29, 2023

Takeda pledges up to $1.13B for rights to Hutchmed’s cancer drug fruquintinib outside of China

Life sciences

Takeda of Japan has partnered with Hong Kong-based Hutchmed, gaining the commercial rights to colorectal cancer drug fruquintinib outside of China for $400 million up front, plus $730 million in potential milestone payments. Takeda also will help develop fruquintinib, which can be applied to subtypes of refractory metastatic colorectal cancer, regardless of biomarker status, the companies said.

January 29, 2023

Vir taps Bayer dealmaker Marianne De Backer as its next CEO

Life sciences

On April 3, Scangos, who’s been chief executive officer at Vir since the start of 2017, will hand over the reins to Marianne De Backer, Ph.D. De Backer comes over from Bayer, where she currently heads up pharmaceutical strategy, business development and licensing. Alongside her CEO appointment, De Backer is set to join Vir’s board of directors, the company said Wednesday.

How can we help you?

We're easy to reach